IL Science (Korea) Probability of Future Stock Price Finishing Over 2800.0
| 307180 Stock | KRW 2,860 10.00 0.35% |
307180 |
IL Science Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of IL Science for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for IL Science can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| IL Science Co has accumulated 6.41 B in total debt with debt to equity ratio (D/E) of 2.99, implying the company greatly relies on financing operations through barrowing. IL Science has a current ratio of 0.81, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist IL Science until it has trouble settling it off, either with new capital or with free cash flow. So, IL Science's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like IL Science sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for 307180 to invest in growth at high rates of return. When we think about IL Science's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 48.63 B. Net Loss for the year was (7.68 B) with profit before overhead, payroll, taxes, and interest of 2.39 B. | |
| IL Science Co has accumulated about 7.05 B in cash with (7.12 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 153.18. | |
| Roughly 36.0% of IL Science shares are owned by insiders or employees |
IL Science Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of 307180 Stock often depends not only on the future outlook of the current and potential IL Science's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. IL Science's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 22.4 M | |
| Cash And Short Term Investments | 8.1 B |
IL Science Technical Analysis
IL Science's future price can be derived by breaking down and analyzing its technical indicators over time. 307180 Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of IL Science Co. In general, you should focus on analyzing 307180 Stock price patterns and their correlations with different microeconomic environments and drivers.
IL Science Predictive Forecast Models
IL Science's time-series forecasting models is one of many IL Science's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary IL Science's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about IL Science
Checking the ongoing alerts about IL Science for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for IL Science help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| IL Science Co has accumulated 6.41 B in total debt with debt to equity ratio (D/E) of 2.99, implying the company greatly relies on financing operations through barrowing. IL Science has a current ratio of 0.81, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist IL Science until it has trouble settling it off, either with new capital or with free cash flow. So, IL Science's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like IL Science sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for 307180 to invest in growth at high rates of return. When we think about IL Science's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 48.63 B. Net Loss for the year was (7.68 B) with profit before overhead, payroll, taxes, and interest of 2.39 B. | |
| IL Science Co has accumulated about 7.05 B in cash with (7.12 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 153.18. | |
| Roughly 36.0% of IL Science shares are owned by insiders or employees |
Other Information on Investing in 307180 Stock
IL Science financial ratios help investors to determine whether 307180 Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 307180 with respect to the benefits of owning IL Science security.